Thomas Landrain, AXA Fellow in 2009, is a fervent defender of open science and a pioneer of a "Do It Yourself" approach of science. Thomas is the founder of La Paillasse, the first community laboratory in France. He is also co-founder and president of JOGL (Just One Giant Lab), the first research and innovation laboratory operating as a distributed, open and massive mobilization platform for collaborative task solving of general interest issues.
To face the challenges of COVID-19, JOGL launched the OpenCovid19 initiative in February 2020 with a goal to find fast, efficient and low-cost solutions in prevention, diagnosis and treatment of COVID19 with the collaborative input of engineers, researchers and computer scientists. One of the immediate projects is to provide solutions in the development of equipment such as protective masks or respirators.
The AXA Research Fund is specifically geared to the operation of the open research platform and the prototyping of promising equipment.
By the end of March, the platform had received over 3,000 contributions from all over the world and around fifty prototypes of masks that could be produced at low cost were offered for testing to users.
More information :
April 2020
Discover the other AXA Research Fund supported COVID19 initiatives
READ THE ARTICLEDiscover research projects related to the topic
Mental Health & Neurology
AXA Chair
Belgium
Neuropsychiatric Diseases and Basal Ganglia: Underlying Mechanisms
A central hub in the brain, the basal ganglia governs a diverse array of functions including voluntary movement, procedural memory, habit... Read more
Alban
DE KERCHOVE D'EXAERDE
Université libre de Bruxelles
Pierre
VANDERHAEGHEN
Université libre de Bruxelles
Women's Health
AXA Chair
Spain
Understanding Menopause's Effect on Women's Cardiovascular Risk
Cardiovascular disease (CVD) is the leading cause of mortality for women worldwide, yet women remain understudied. Atherosclerosis, the main pathology... Read more
.thumbnail.jpg)
Inés
PINEDA-TORRA